ProstaLund (Sweden) Insiders
| PLUN Stock | SEK 9.00 2.00 28.57% |
ProstaLund employs about 7 people. The company is managed by 5 executives with a total tenure of roughly 17 years, averaging almost 3.0 years of service per executive, having 1.4 employees per reported executive. Breaking down ProstaLund's management performance can provide insight into the firm performance.
| Erika Carlsson Insider Chief Officer |
| Charlotta Andersson Insider Sales Finland |
ProstaLund |
ProstaLund Management Team Effectiveness
The company has return on total asset (ROA) of (0.1309) % which means that it has lost $0.1309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2484) %, meaning that it generated substantial loss on money invested by shareholders. ProstaLund's management efficiency ratios could be used to measure how well ProstaLund manages its routine affairs as well as how well it operates its assets and liabilities.ProstaLund Workforce Comparison
ProstaLund AB is considered to be number one stock in number of employees category among its peers. The total workforce of Medical Care Facilities industry is at this time estimated at about 85.0. ProstaLund holds roughly 7.0 in number of employees claiming about 8% of all equities under Medical Care Facilities industry.
The company has Profit Margin (PM) of (0.61) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.59. ProstaLund AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ProstaLund AB Price Series Summation is a cross summation of ProstaLund price series and its benchmark/peer.
ProstaLund Notable Stakeholders
A ProstaLund stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ProstaLund often face trade-offs trying to please all of them. ProstaLund's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ProstaLund's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Erika Carlsson | Chief Officer | Profile | |
| Charlotta Andersson | Sales Finland | Profile | |
| Goran Dybner | Marketing Director | Profile | |
| Leo Gurvich | Chief Marked | Profile | |
| Johan Wennerholm | Chief Officer | Profile |
About ProstaLund Management Performance
The success or failure of an entity such as ProstaLund AB often depends on how effective the management is. ProstaLund management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ProstaLund management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ProstaLund management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ProstaLund AB develops, manufactures, and sells urological devices and treatments.
Please note, the imprecision that can be found in ProstaLund's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ProstaLund AB. Check ProstaLund's Beneish M Score to see the likelihood of ProstaLund's management manipulating its earnings.
ProstaLund Workforce Analysis
Traditionally, organizations such as ProstaLund use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ProstaLund within its industry.ProstaLund Manpower Efficiency
Return on ProstaLund Manpower
| Revenue Per Employee | 2.4M | |
| Revenue Per Executive | 3.4M | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 1.6M |
Additional Tools for ProstaLund Stock Analysis
When running ProstaLund's price analysis, check to measure ProstaLund's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProstaLund is operating at the current time. Most of ProstaLund's value examination focuses on studying past and present price action to predict the probability of ProstaLund's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProstaLund's price. Additionally, you may evaluate how the addition of ProstaLund to your portfolios can decrease your overall portfolio volatility.